PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 7897316-8 1994 HDL density profiles of the study groups prior to the administration of heparin demonstrated two distinct peaks at density 1.09 g/ml (HDL2) and 1.13 g/ml (HDL3). Heparin 72-79 junctophilin 3 Homo sapiens 134-138 7897316-9 1994 However, after the administration of heparin to the HTG group, only a single peak in the HDL profile was evident that was located at the density region corresponding to HDL2 (1.09 g/ml). Heparin 37-44 junctophilin 3 Homo sapiens 169-173 2400395-7 1990 3H-labelled HDL2 and HDL3 subfractions behaved differently under the precipitant action of heparin-Mn2+; fraction C (the richest in apolipoprotein E) produced the largest amount of radioactive and chemical precipitate. Heparin 91-98 junctophilin 3 Homo sapiens 12-16 7822240-5 1994 Apolipoprotein (apo) E-free HDL2 from the patients, separated by heparin-Sepharose column chromatography, was rich in CE, poor in triglycerides (TG), and enlarged in size on 4-30% nondenaturing polyacrylamide gradient gel electrophoresis. Heparin 65-72 junctophilin 3 Homo sapiens 28-32 1364970-5 1992 The in vivo acceleration of lipoprotein metabolism by heparin resulted in: 1) the reduction of VLDL-TAG and HDL2-TAG, and in the increase of HDL3-TAG, 2) the appearance of positive relation of HDL2-C to the LPL activity and of opposite relation to the HL activity, 3) the lack of HL correlation to the TAG of HDL and HDL3. Heparin 54-61 junctophilin 3 Homo sapiens 108-112 1364970-5 1992 The in vivo acceleration of lipoprotein metabolism by heparin resulted in: 1) the reduction of VLDL-TAG and HDL2-TAG, and in the increase of HDL3-TAG, 2) the appearance of positive relation of HDL2-C to the LPL activity and of opposite relation to the HL activity, 3) the lack of HL correlation to the TAG of HDL and HDL3. Heparin 54-61 junctophilin 3 Homo sapiens 193-197 6697533-1 1984 Gidez et al described a double precipitation method with polyanions to separate high density lipoprotein (HDL) subfractions, using sodium heparin to precipitate very low density lipoprotein (VLDL) and low density lipoprotein (LDL) first, and dextran sulphate 15000 to precipitate HDL2 from total HDL afterwards. Heparin 131-145 junctophilin 3 Homo sapiens 280-284 2151097-4 1990 The obtained results call attention to the importance of final concentration of Mn2+ ions at HDL2 precipitation with DS from heparin-Mn2+ supernate containing HDL. Heparin 125-132 junctophilin 3 Homo sapiens 93-97 7175378-5 1982 HDL2 cholesterol is calculated as the difference between total HDL cholesterol (heparin-Mn2+ supernatant) and HDL3 cholesterol (dextran sulfate supernatant). Heparin 80-87 junctophilin 3 Homo sapiens 0-4 7314590-4 1981 Administration of heparin into the patients was responsible for an increase in the level of unsaturated phospholipids in HDL2 fraction (while they decreased in VLDL/as well as for a decrease in the ratio cholesterol/phospholipids. Heparin 18-25 junctophilin 3 Homo sapiens 121-125 7046999-1 1982 Recent evidence has suggested that the major physiological substrate of the heparin-releasable (postheparin plasma) hepatic lipase is HDL2-phospholipid. Heparin 76-83 junctophilin 3 Homo sapiens 134-138 7123544-3 1982 The result, in conjunction with the HDL-cholesterol concentration simultaneously determined by the heparin-Ca2+ method, enabled us to calculate the HDL2- and HDL3-cholesterol concentrations. Heparin 99-106 junctophilin 3 Homo sapiens 148-152 7418200-5 1980 Heparin affinity chromatography of HDL2 in the presence of Ca2+ and Mn2+ showed an interaction of apolipoprotein E-containing HDL2 subfraction only in conditions involving Mn2+. Heparin 0-7 junctophilin 3 Homo sapiens 35-39 7418200-5 1980 Heparin affinity chromatography of HDL2 in the presence of Ca2+ and Mn2+ showed an interaction of apolipoprotein E-containing HDL2 subfraction only in conditions involving Mn2+. Heparin 0-7 junctophilin 3 Homo sapiens 126-130 7285347-5 1981 The method provides an alternative to the recently described heparin/MnCl2/dextran sulphate double-precipitation procedure, with the advantage of permitting quantitative recovery of intact HDL2. Heparin 61-68 junctophilin 3 Homo sapiens 189-193